Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”

Saved in:
Bibliographic Details
Main Authors: Rui Shi, Minghua Wang
Format: Article
Language:English
Published: Korean Association for the Study of the Liver 2025-04-01
Series:Clinical and Molecular Hepatology
Subjects:
Online Access:http://e-cmh.org/upload/pdf/cmh-2024-1159.pdf
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850147263143215104
author Rui Shi
Minghua Wang
author_facet Rui Shi
Minghua Wang
author_sort Rui Shi
collection DOAJ
format Article
id doaj-art-c2cf50608f764008b34ea61b53cd3d95
institution OA Journals
issn 2287-2728
2287-285X
language English
publishDate 2025-04-01
publisher Korean Association for the Study of the Liver
record_format Article
series Clinical and Molecular Hepatology
spelling doaj-art-c2cf50608f764008b34ea61b53cd3d952025-08-20T02:27:35ZengKorean Association for the Study of the LiverClinical and Molecular Hepatology2287-27282287-285X2025-04-01312e137e13910.3350/cmh.2024.11592143Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”Rui Shi0Minghua Wang1 Department of Biology, Xinzhou Teachers University, Xinzhou, Shanxi, China Department of Biology, Xinzhou Teachers University, Xinzhou, Shanxi, Chinahttp://e-cmh.org/upload/pdf/cmh-2024-1159.pdfchronic kidney diseaseend-stage renal diseaseliver transplantintrapatient variability
spellingShingle Rui Shi
Minghua Wang
Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
Clinical and Molecular Hepatology
chronic kidney disease
end-stage renal disease
liver transplant
intrapatient variability
title Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
title_full Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
title_fullStr Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
title_full_unstemmed Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
title_short Tacrolimus levels and variability in CKD and ESRD risk post-liver transplant: Letter to the editor on “Optimal tacrolimus levels for reducing CKD risk and the impact of intrapatient variability on CKD and ESRD development following liver transplantation”
title_sort tacrolimus levels and variability in ckd and esrd risk post liver transplant letter to the editor on optimal tacrolimus levels for reducing ckd risk and the impact of intrapatient variability on ckd and esrd development following liver transplantation
topic chronic kidney disease
end-stage renal disease
liver transplant
intrapatient variability
url http://e-cmh.org/upload/pdf/cmh-2024-1159.pdf
work_keys_str_mv AT ruishi tacrolimuslevelsandvariabilityinckdandesrdriskpostlivertransplantlettertotheeditoronoptimaltacrolimuslevelsforreducingckdriskandtheimpactofintrapatientvariabilityonckdandesrddevelopmentfollowinglivertransplantation
AT minghuawang tacrolimuslevelsandvariabilityinckdandesrdriskpostlivertransplantlettertotheeditoronoptimaltacrolimuslevelsforreducingckdriskandtheimpactofintrapatientvariabilityonckdandesrddevelopmentfollowinglivertransplantation